Subscribe to Moneycontrol Pro and get 365 bonus InterMiles! Use Code: INTERMILES
you are here: HomeNewsIndia
Last Updated : Oct 17, 2020 07:47 PM IST | Source: PTI

Daily Maharashtra COVID-19 test numbers have dipped in October: Devendra Fadnavis

In a letter to the chief minister, Devendra Fadnavis said the average number of tests per day between October 1 and 15 was 75,296, down from 91,743 during the September 16 to 30 period and 84,675 in the September 1 to 15 period.


Senior BJP leader Devendra Fadnavis on Saturday said the Uddhav Thackeray government must increase the number of COVID-19 determination tests in Maharashtra as the daily average was on a downward trend since September 1.

In a letter to the chief minister, Fadnavis said the average number of tests per day between October 1 and 15 was 75,296, down from 91,743 during the September 16 to 30 period and 84,675 in the September 1 to 15 period.

He said the low number of tests in October might be behind the reduction in coronavirus numbers on a daily basis, which he claimed was "hiding reality".


The leader of opposition in the state Assembly said Maharashtra's death per million figure was high and so was the case for Mumbai. The national death per million figure was 97.6 while it was as high as 333 in Maharashtra, the former CM claimed.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"In Mumbai, the infection ratio in the first fortnight of September was 15.95 percent which increased to 17.61 percent in the second fortnight of September and remained 17.39 percent in the first fortnight of October," Fadnavis said, wondering why test numbers were not being ramped up despite "high prevalence of infection".

He said the rising infection numbers in the state meant all sectors of the economy cannot resume operations.
First Published on Oct 17, 2020 07:47 pm